AUL
BSX icon

AlphaGrep UK Ltd’s Boston Scientific BSX Stock Holding History

AlphaGrep UK Ltd’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$732K Sell
11,661
-276
-2% -$22.1K 0.21% 99
2025
Q4 		$1.14M Buy
+11,937
New +$1.17M 0.38% 24

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AlphaGrep UK Ltd's BSX Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its Boston Scientific (BSX) stake by 2.3% in Q1 2026, selling an estimated $22.1K and leaving 11,661 shares worth $732K. The position accounts for 0.21% of the portfolio, ranked #99.

AlphaGrep UK Ltd first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.14M in Q4 2025. 1,675 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • AlphaGrep UK Ltd held 11,661 shares of Boston Scientific worth $732K as of Q1 2026.
  • AlphaGrep UK Ltd sold 276 Boston Scientific shares in Q1 2026, an estimated $22.1K.
  • Boston Scientific made up 0.21% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #99 holding.
  • AlphaGrep UK Ltd first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's Boston Scientific position peaked at $1.14M in Q4 2025.
  • 1,675 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.